NeuroOne to Present at Planet MicroCap Las Vegas 2026 Conference

NeuroOne Medical Technologies will present at the Planet MicroCap Las Vegas 2026 Conference, providing commercialization updates and milestones for its OneRF platform.

Miami Metrowire Staff
Healthcare
NeuroOne to Present at Planet MicroCap Las Vegas 2026 Conference

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company focused on advancing surgical diagnosis and treatment for neurological disorders, announced today that it will participate in the Planet MicroCap Las Vegas 2026 Conference, scheduled for June 17-18, 2026. Dave Rosa, President and Chief Executive Officer, will attend the conference in Las Vegas, Nevada, where he is set to host one-on-one meetings with institutional investors and deliver a company presentation on Wednesday, June 17, 2026, at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time in TRACK 6 - Raphael 3.

During the presentation, Rosa will provide updates on the company's commercialization progress and anticipated milestones for the OneRF® platform, which is designed for treatment of the brain, pain management, and advanced drug delivery. Additionally, Rosa participated in a CEO interview with Planet MicroCap host Robert Kraft ahead of the conference, which can be viewed here. The company's presentation will also be accessible via a webcast link here.

NeuroOne's participation in the conference underscores its commitment to engaging with the investment community and highlighting its progress in the medical technology sector. The company markets a minimally invasive, high-definition electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions aim to reduce hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering both diagnostic and therapeutic functions.

In addition to its current product lines, NeuroOne is engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs. The company's presentation at the Planet MicroCap Conference is expected to provide investors with insights into its strategic direction and upcoming milestones. For more information about the conference or to schedule a meeting with management, interested parties can contact their conference representative or email NMTC@mzgroup.us. Further details about NeuroOne can be found on its website at nmtc1.com.

Blockchain Registration

QR Code for Blockchain Registration